https://www.selleckchem.com/pr....oducts/cycloheximide
Please see http//www.annualreviews.org/page/journal/pubdates for revised estimates.Background Despite recent progress in screening survival-related genes, there have been few attempts to apply methods based on cancer stem cells (CSCs) for prognosis. We aimed to identify a CSC-based model to predict survival in colorectal cancer (CRC) patients. Material/methods Differentially expressed genes between CRC and normal tissues and between CD133- and CD133+ cells were obtained from The Cancer Genome Atlas and Gene Expression Omnibus, and